Cramer’s lightning round: Vir and GlaxoSmithKline may have something that could fight omicron – CNBC

Vir Biotechnology (VIR): “[George Scangos] runs that company. And I have to tell you he’s part of a GlaxoSmithKline [alliance]. And I spend a lot of time talking to GlaxoSmithKline. They may have som… [+935 chars]